APGE Apogee Therapeutics, Inc.
$81.81
▼ 3.23%
39
Value
30
P/E-19.41
8
P/B5.49
44
P/S0.00
70
EV/EBITDA-17.77
5
Growth
36
Revenue Growth0.0%
28
EPS Growth-27.9%
41
FCF Growth-35.0%
40
Momentum
80
12-Month Return130.0%
100
3-Month Return31.7%
100
1-Month Return-1.6%
50
RSI (14)26.31
60
50/200 MABullish
75
Profitability
19
ROE-36.8%
44
ROA-27.3%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-4.6%
0
Risk
25
Beta0.69
55
60-Day Volatility57.2%
0
QScore Analysis